Archives
-
NHE1, Olfr2, and Octanal in Macrophage Atherosclerosis
2026-08-23
This Scientific Reports study identifies macrophage NHE1 as a downstream effector of octanal–Olfr2 signaling in atherosclerosis. Using ApoE−/− mice and RAW264.7 macrophages, the authors link NHE1 activity to calcium-dependent ROS production, NLRP3 inflammasome activation, foam-cell formation, and vascular inflammation.
-
Nurr1 Neurogenetic Gradients in the Rat Claustrum
2026-08-22
Fang, Wang, and Naumann mapped the emergence and embryonic birth timing of Nurr1-positive neurons across the rat claustrum and adjacent lateral cortex. By combining developmental Nurr1 expression profiling with EdU birth dating, the study identifies sequential neurogenesis and spatial gradients that refine interpretation of claustrum boundaries and ontogeny.
-
Apicidin: Histone Deacetylase Inhibitor Workflows
2026-08-22
Apicidin combines potent HDAC3-directed activity with practical utility in cancer, chromatin, parasite, and reproductive-toxicity assays. This workflow-focused guide shows how to control solubility, separate epigenetic effects from general cytotoxicity, and translate meiotic-quality findings into robust experimental readouts.
-
mRAVE Assembly of Metazoan V-ATPase After Gradient Loss
2026-08-21
The reference study identifies mRAVE, a metazoan RAVE complex built from DMXL1 or DMXL2, WDR7, and ROGDI, and shows that it promotes V-ATPase reassembly after proton-gradient dissipation. Its genetic, cell-based, and biochemical evidence connects this assembly pathway with lysosomal acidification, vesicular neurotransmitter loading, and ATG16L1-dependent membrane autophagy pathways.
-
Cy3 Goat Anti-Mouse IgG (H+L) Antibody
2026-08-20
Cy3 Goat Anti-Mouse IgG (H+L) Antibody provides a Cy3-labeled secondary reagent for detecting mouse primary antibodies in immunofluorescence, flow cytometry, and western blot workflows. It is not a directly validated diagnostic reagent, and assay-specific dilution, fixation, blocking, and imaging conditions should be established experimentally because no directly matched paper evidence is supplied for SKU K1207.
-
Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding
2026-08-20
The reference study identifies a previously underappreciated interaction between naturally occurring angiotensin peptides and SARS-CoV-2 spike-protein receptor binding. Its peptide-truncation and residue-modification experiments show that shorter or modified angiotensin sequences can enhance spike binding to AXL, ACE2, and neuropilin-1, while the longer Angiotensin I decapeptide does not enhance spike–AXL binding.
-
Deep Learning for iPSC-CM Cardiotoxicity Screening
2026-08-19
Grafton and colleagues combined high-content imaging, induced pluripotent stem cell-derived cardiomyocytes, and deep learning to detect cardiotoxic patterns across a 1,280-compound bioactive library. The study shows how a scalable, single-score phenotypic screen can prioritize diverse chemical liabilities before development reaches late-stage safety testing, while also highlighting the need for orthogonal mechanistic validation.
-
Roscovitine: CDK Workflows for Cancer Research
2026-08-19
Roscovitine, also called Seliciclib or CYC202, gives researchers a reversible way to interrogate CDK-driven proliferation, late-prophase control, and treatment-response confounding. This guide translates its biochemical profile into practical cell-cycle, radiotherapy, and immune-assay workflows while clearly separating established evidence from hypothesis-generating applications.
-
Cy5 Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-08-18
The Cy5 Goat Anti-Mouse IgG (H+L) Antibody is an affinity-purified, Cy5-conjugated secondary antibody for mouse IgG detection in immunohistochemistry, immunocytochemistry, and flow cytometry. Its H+L reactivity and product-defined storage conditions support flexible fluorescent workflows, but it does not independently establish osteogenic mechanisms.
-
Early Pheromone Sensing Drives C. elegans Neurodegeneration
2026-08-18
Peng et al. show that exposure to the pheromones ascr#3 and ascr#10 during the L1 stage reprograms neural development and accelerates neurodegeneration in adult C. elegans. The study defines a circuit from ASK and ASI chemosensory neurons through AIA interneurons to insulin-like signaling and neuronal autophagy, offering a mechanistic framework for how early environmental cues can shape late-life proteostasis.
-
Cotton Gland Size and Phytoalexin Feedback
2026-08-17
The reference study identifies a negative feedback loop between the MYC2-like factor GoPGF and the VQ protein JAVL that coordinates cotton pigment-gland development, jasmonate homeostasis, and defense-metabolite production. Its findings suggest that the relative activity of these regulators, rather than either factor alone, may provide a tunable route to stronger resistance against insects and pathogens.
-
Adefovir (GS-0393): HBV Mechanism & Research Guide
2026-08-17
Adefovir, also known as GS-0393, is an HBV antiviral agent that forms adefovir diphosphate and inhibits viral DNA synthesis. Its reported OAT1 transport parameters and defined solubility profile support separate antiviral and renal transporter workflows.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody
2026-08-16
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody detects goat-derived IgG primary antibodies in fluorescence-based ICC/IF, IHC, flow cytometry, and ELISA workflows. It should not be used as a direct antigen-detection reagent, with non-goat primary antibodies, or as a substitute for enzyme-conjugated detection chemistry.
-
HyperFusion high-fidelity DNA polymerase for PCR
2026-08-15
HyperFusion high-fidelity DNA polymerase combines proofreading accuracy with speed and inhibitor tolerance for cloning, genotyping, GC-rich targets, and long amplicons. This workflow-focused guide shows how to translate a C. elegans neurodegeneration study into sequence-validated PCR assays while troubleshooting difficult templates efficiently.
-
Cy3 Goat Anti-Human IgG (H+L) Antibody Guide
2026-08-14
Build sensitive human IgG readouts across immunofluorescence, tissue staining, flow cytometry, and ELISA with a Cy3 conjugated secondary antibody. This workflow also shows how orthopoxvirus antibody studies can guide antigen-resolved assay design without confusing binding measurements with antiviral protection.